Methicillin-resistant Staphylococcus aureus:: An evolutionary, epidemiologic, and therapeutic odyssey

被引:301
作者
Deresinski, S
机构
[1] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA USA
[2] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA
关键词
D O I
10.1086/427701
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Methicillin-resistant Staphylococcus aureus, first identified just over 4 decades ago, has undergone rapid evolutionary changes and epidemiologic expansion. It has spread beyond the confines of health care facilities, emerging anew in the community, where it is rapidly becoming a dominant pathogen. This has led to an important change in the choice of antibiotics in the management of community-acquired infections and has also led to the development of novel antimicrobials.
引用
收藏
页码:562 / 573
页数:12
相关论文
共 162 条
[1]   Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin [J].
Aarestrup, FM .
MICROBIAL DRUG RESISTANCE, 1998, 4 (02) :137-141
[2]   Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections [J].
Adra, M ;
Lawrence, KR .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) :338-341
[3]   Mechanism of action of oritavancin and related glycopeptide antibiotics [J].
Allen, NE ;
Nicas, TI .
FEMS MICROBIOLOGY REVIEWS, 2003, 26 (05) :511-532
[4]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P902
[5]  
[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P707
[6]  
[Anonymous], 43 ANN INT C ANT AG
[7]  
APPELBAUM P, 2003, J THROMB HAEMOST S1, V1, P915
[8]   Microbiology - Signaling antibiotic resistance in staphylococci [J].
Archer, GL ;
Bosilevac, JM .
SCIENCE, 2001, 291 (5510) :1915-1916
[9]   Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia [J].
Azoulay-Dupuis, E ;
Bédos, JP ;
Mohler, J ;
Schmitt-Hoffmann, A ;
Schleimer, M ;
Shapiro, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1105-1111
[10]   Genome and virulence determinants of high virulence community-acquired MRSA [J].
Baba, T ;
Takeuchi, F ;
Kuroda, M ;
Yuzawa, H ;
Aoki, K ;
Oguchi, A ;
Nagai, Y ;
Iwama, N ;
Asano, K ;
Naimi, T ;
Kuroda, H ;
Cui, L ;
Yamamoto, K ;
Hiramatsu, K .
LANCET, 2002, 359 (9320) :1819-1827